Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Kelyniam received a exclusive U.S. license from Evonik to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material, for cranial implants
-
Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
-
Applied StemCell uses TARGATT™ tech to insert a 50 kb multifunctional DNA construct into hiPSCs, enabling development of allogeneic iPSC-based therapies.
-
Dublin, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The "United States Regenerative Medicine Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F" report has been added to ...
-
CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its...
-
Pluristyx signs key clinical use licenses for its iPSC platform, enabling new regenerative and neurological disease therapies.
-
TORONTO and HAIFA, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) announced today that it has been accepted to...
-
Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country -...
-
Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Europe Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country - Analysis...
-
Torrance, CA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Christina Wang, MD, and Lynda Polgreen, MD, MS, investigators at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, have...